Eagle Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 66 U.S.-traded ETFs. EGRX has around 2.5M shares in the U.S. ETF market. The largest ETF holder of EGRX is the iShares Core S&P Small-Cap ETF (IJR), with approximately 625.51K shares. Investors may also find of interest that the ETF with the largest allocation to EGRX stock is Invesco Dynamic Pharmaceuticals ETF (PJP), with a portfolio weight of 2.40%. On average, U.S. ETFs allocate 0.14% of EGRX to their portfolios.
Additionally, EGRX is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with EGRX as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 46.99%.